FibroBiologics, Inc. (FBLG) stock
FBLGNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.90−0.02 (-2.56%)
Close on Nov 16, 2026Market cap $6.02MP/E –Yield –
FibroBiologics total assets
Total assets on the balance sheet at the end of each period.
FibroBiologics's total assets was $7.93M at Jun 30, 2026. For fiscal 2025 it was $9.62M, down 41.5% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.62M | -41.5% |
| FY2024 | Dec 31, 2024 | $16.45M | +39.1% |
| FY2023 | Dec 31, 2023 | $11.82M | +145.0% |
| FY2022 | Dec 31, 2022 | $4.82M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $7.93M | -43.0% |
| Q1 FY2026 | Mar 31, 2026 | $5.94M | -48.0% |
| Q4 FY2025 | Dec 31, 2025 | $9.62M | -41.5% |
| Q3 FY2025 | Sep 30, 2025 | $8.74M | -16.5% |
| Q2 FY2025 | Jun 30, 2025 | $13.91M | +56.0% |
| Q1 FY2025 | Mar 31, 2025 | $11.43M | +0.2% |
| Q4 FY2024 | Dec 31, 2024 | $16.45M | +39.1% |
| Q3 FY2024 | Sep 30, 2024 | $10.47M | +117.0% |
| Q2 FY2024 | Jun 30, 2024 | $8.91M | – |
| Q1 FY2024 | Mar 31, 2024 | $11.40M | – |
| Q4 FY2023 | Dec 31, 2023 | $11.82M | – |
| Q4 FY2022 | Dec 31, 2022 | $4.82M | – |
See a number that looks wrong?